• SENSEX 82,625.37
    570.26 (+0.69%)
  • BANKNIFTY 56,461.90
    402.55 (+0.72%)
  • Garden Reach Sh.
    3,051.30 1,180.10(%)
  • Enviro Infra
    251.85 392.00(%)
  • Waaree Energies
    3,097.15 3,740.75(%)
  • Multi Comm. Exc.
    8,808.85 8,357.25(%)
  • Welspun Living
    142.00 213.10(%)
  • Vodafone Idea
    7.19 19.15(%)
  • Bharat Electron
    409.30 240.15(%)
  • M T N L
    57.90 101.88(%)
  • Cochin Shipyard
    2,123.00 1,180.45(%)
  • Mazagon Dock
    3,224.45 1,917.95(%)
  • Netwrk.18 Media
    61.82 106.01(%)
  • Hind.Aeronautics
    4,800.00 3,045.95(%)
  • Hyundai Motor I
    2,145.00 2,083.60(%)
  • BEML Ltd
    4,422.00 2,346.35(%)
  • Vishal Mega Mart
    137.80 134.50(%)
  • Tata Motors
    678.80 1,179.05(%)
  • Dixon Technolog.
    14,090.00 10,613.00(%)
  • Sammaan Capital
    143.85 179.35(%)
  • Suzlon Energy
    63.93 46.00(%)
  • Bharat Dynamics
    1,821.75 897.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Sarabhai Ent
  • BSE Code : 14.0
  • ISIN : INE432A01017
35.73 0 (1.13%)
  • As on 25 Jun 2025 (EOD)

  • Today’s Low

    35.06

  • Today’s High

    36.30

  • Open

    35.76

  • Perv Close

    35.33

  • 52W Low

    34.11

  • 52W High

    77.70

Key Indicators

  • P/E(TTM)

    35.73

  • Mar.Cap (₹Cr.)

    273.81

  • Div & Yield %

    0.00

  • Book Value(₹)

    6.33

  • Debt-Equity Ratio

    1.13

  • AGM Date

    24-Jun-2025

  • EPS

    1.00

  • P/E Ratio

    35.73

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    273.81

  • RONW (%)

    3.98

  • ROCE (%)

    6.73

Score Board

  • Equity (₹ in Cr.)

    76.63

  • BV (₹)

    6.30

  • Sales( ₹ in Cr.)

    4.04

  • NP (in Cr.)

    7.69

  • NP Var(%)

    198.0

  • Div%

    0.0

  • CPS (₹)

    1.00

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    273.81

  • 52 Week High

    77.70

  • 52 Week Low

    34.11

  • Price BSE

    36.0

  • Price NSE

    4.00

  • Market Capital( in Cr.)

    273.81

  • P/C Ratio

    35.40

  • P/E Ratio

    35.90

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3.81 3.71 0.13 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3.81 3.71 0.13 0.00 0.00 0.00
Other Income 7.89 18.66 39.54 29.61 24.61 6.46
Stock Adjustments 0.00 0.02 0.00 0.00 0.00 0.00
Total Income 11.70 22.39 39.67 29.61 24.61 6.46
EXPENDITURE :            
Raw Materials 3.71 3.65 0.12 0.00 0.00 0.00
Power and Fuel Cost 0.10 0.10 0.07 0.11 0.08 0.17
Employee Cost 2.04 2.21 2.51 3.26 3.35 4.31
Other Manufacturing Expenses 0.35 0.31 0.35 0.70 0.18 0.39
Selling and Administration Expenses 1.88 2.19 2.04 3.03 3.46 3.10
Miscellaneous Expenses 0.53 9.34 30.68 31.05 0.78 0.90
Employee Benefit Expenses 2.04 2.21 2.51 3.26 3.35 4.31
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8.62 17.80 35.77 38.14 7.85 8.87
Operating Profit 3.09 4.59 3.89 -8.53 16.75 -2.40
Interest 2.16 0.11 0.25 0.56 0.46 0.62
Gross Profit 0.93 4.48 3.64 -9.09 16.29 -3.02
Depreciation 0.12 0.15 0.19 0.38 0.39 0.40
Profit Before Tax 0.81 4.33 3.45 -9.47 15.90 -3.42
Current Tax -2.15 0.00 -0.25 0.21 0.04 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.39 0.23 0.75 -0.29 0.31 0.46
Reported Net Profit 2.58 4.11 2.96 -9.39 15.55 -3.88
Extraordinary Items 0.00 -0.69 -0.43 -6.76 0.28 0.00
Adjusted Net Profit 2.58 4.80 3.39 -2.63 15.27 -3.88
Adjustment below Net Profit 0.00 0.03 0.02 -0.07 -0.09 -0.08
P & L Balance brought forward -105.50 -109.64 -112.62 -103.16 -118.62 -114.66
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -102.92 -105.50 -109.64 -112.62 -103.16 -118.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.34 0.54 0.39 -1.22 2.03 0.00
Earnings Per Share(Adj)-Unit Curr 0.34 0.54 0.39 -1.22 2.03 0.00
Book Value 5.26 4.94 4.40 4.02 5.25 3.23
Book Value(Adj)-Unit Curr 5.26 4.94 4.40 4.02 5.25 3.23

Shareholding Pattern

  • Promoter Group

    31.35%

  • Public Share Holding

    68.65%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 23,672,146 30.89 23,672,146 22
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 349,346 0.46 349,346 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,021,492 31.35 24,021,492 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 77,712 0.10 76,292 15
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 291,037 0.38 291,037 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,700 0.00 0 2
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 370,449 0.48 367,329 19
2] Non Institution
Bodies Corporate 3,927,087 5.12 3,806,710 522
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,268,315 1.66 1,118,283 610
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,812,865 2.37 1,812,865 860
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,258,833 16.00 12,258,833 178
Individuals holding nominal share capital up to Rs. 1 lakh 31,741,727 41.42 19,678,261 168,693
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 140 0.00 140 2
Others 1,232,388 1.61 1,232,388 2
Sub Total 52,241,355 68.17 39,907,480 170,867
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,633,296 100.00 64,296,301 170,912

Company Background

Ambalal Sarabhai Enterprises LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ambalal Sarabhai Enterprises Ltd
  • BSE Code : 14.0
  • ISIN : INE432A01017

  • Incorporation Year

    1977

  • Registered Office

    Shanti Sadan
    Mirzapur Road, Ahmedabad,
    Gujarat-380001

  • Telephone

    91-79-25507671/25507073

  • FAX

    91-79-25507483

  • Chairman

    Kartikeya V Sarabhai

  • Managing Director

    Mohal Kartikeya Sarabhai

  • Company Secretary

    Damodar Sejpal

  • Auditor

    Sorab S Engineer & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MCS Limited
    Neelam Apt 88,
    Sampat Rao Colony,Po Race Course
    Mumbai - Vadodara 390007

Ambalal Sarabhai Enterprises Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ambalal Sarabhai 35.73 11.70 3.81 33.08 1.92
Abbott India 31,510.65 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 8,798.50 1,330.33 1,295.53 190.03 33.26
P & G Health Ltd 5,912.35 1,166.89 1,151.26 39.07 39.76
Glaxosmi. Pharma 3,227.35 3,866.05 3,723.49 59.49 58.72
Cipla 1,502.85 20,029.57 19,044.85 23.53 21.40
Novartis India 1,015.05 396.75 335.07 24.84 15.57
Amrutanjan Healt 720.20 437.58 421.23 40.97 20.84
Guj. Themis Bio. 331.75 174.19 169.82 74.05 44.82
Fermenta Biotec. 305.00 315.24 307.09 13.28 4.10
Bliss GVS Pharma 148.60 638.96 605.46 22.69 11.19